218 related articles for article (PubMed ID: 29358704)
61. Identification of NOG as a specific breast cancer bone metastasis-supporting gene.
Tarragona M; Pavlovic M; Arnal-Estapé A; Urosevic J; Morales M; Guiu M; Planet E; González-Suárez E; Gomis RR
J Biol Chem; 2012 Jun; 287(25):21346-55. PubMed ID: 22547073
[TBL] [Abstract][Full Text] [Related]
62. GATA3 in development and cancer differentiation: cells GATA have it!
Chou J; Provot S; Werb Z
J Cell Physiol; 2010 Jan; 222(1):42-9. PubMed ID: 19798694
[TBL] [Abstract][Full Text] [Related]
63. Subtype-Independent ANP32E Reduction During Breast Cancer Progression in Accordance with Chromatin Relaxation.
Ruff GL; Murphy KE; Smith ZR; Vertino PM; Murphy PJ
BMC Cancer; 2021 Dec; 21(1):1342. PubMed ID: 34922480
[TBL] [Abstract][Full Text] [Related]
64. Trefoil factor-1 upregulation in estrogen-receptor positive breast cancer correlates with an increased risk of bone metastasis.
Spadazzi C; Mercatali L; Esposito M; Wei Y; Liverani C; De Vita A; Miserocchi G; Carretta E; Zanoni M; Cocchi C; Bongiovanni A; Recine F; Kang Y; Ibrahim T
Bone; 2021 Mar; 144():115775. PubMed ID: 33249323
[TBL] [Abstract][Full Text] [Related]
65. FOXA1 and breast cancer risk.
Meyer KB; Carroll JS
Nat Genet; 2012 Nov; 44(11):1176-7. PubMed ID: 23104063
[TBL] [Abstract][Full Text] [Related]
66. Tumor dormancy in bone.
Mayhew V; Omokehinde T; Johnson RW
Cancer Rep (Hoboken); 2020 Feb; 3(1):e1156. PubMed ID: 32632400
[TBL] [Abstract][Full Text] [Related]
67. How to Predict Metastasis in Luminal Breast Cancer? Current Solutions and Future Prospects.
Tabor S; Szostakowska-Rodzos M; Fabisiewicz A; Grzybowska EA
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182512
[TBL] [Abstract][Full Text] [Related]
68. Gene expression predicts dormant metastatic breast cancer cell phenotype.
Ren Q; Khoo WH; Corr AP; Phan TG; Croucher PI; Stewart SA
Breast Cancer Res; 2022 Jan; 24(1):10. PubMed ID: 35093137
[TBL] [Abstract][Full Text] [Related]
69. Noncanonical Activity of Med4 as a Gatekeeper of Metastasis through Epigenetic Control of Integrin Signaling.
Bae SY; Chen Y; Chen H; Kumar D; Karaiskos S; Xu J; Lu C; Viny AD; Giancotti FG
bioRxiv; 2024 Jan; ():. PubMed ID: 38014033
[TBL] [Abstract][Full Text] [Related]
70. Publisher Correction: MSK1 regulates luminal cell differentiation and metastatic dormancy in ER
Gawrzak S; Rinaldi L; Gregorio S; Arenas EJ; Salvador F; Urosevic J; Figueras-Puig C; Rojo F; Del Barco Barrantes I; Cejalvo JM; Palafox M; Guiu M; Berenguer-Llergo A; Symeonidi A; Bellmunt A; Kalafatovic D; Arnal-Estapé A; Fernández E; Müllauer B; Groeneveld R; Slobodnyuk K; Stephan-Otto Attolini C; Saura C; Arribas J; Cortes J; Rovira A; Muñoz M; Lluch A; Serra V; Albanell J; Prat A; Nebreda AR; Benitah SA; Gomis RR
Nat Cell Biol; 2018 Aug; 20(8):990. PubMed ID: 29674681
[TBL] [Abstract][Full Text] [Related]
71. Illuminating MSK1's role in tumour dormancy.
Grzelak CA; Ghajar CM
Nat Cell Biol; 2018 Feb; 20(2):124-126. PubMed ID: 29371707
[No Abstract] [Full Text] [Related]
72. TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis.
Tauriello DVF; Palomo-Ponce S; Stork D; Berenguer-Llergo A; Badia-Ramentol J; Iglesias M; Sevillano M; Ibiza S; Cañellas A; Hernando-Momblona X; Byrom D; Matarin JA; Calon A; Rivas EI; Nebreda AR; Riera A; Attolini CS; Batlle E
Nature; 2018 Feb; 554(7693):538-543. PubMed ID: 29443964
[TBL] [Abstract][Full Text] [Related]
73. STAT3/p53 pathway activation disrupts IFN-β-induced dormancy in tumor-repopulating cells.
Liu Y; Lv J; Liu J; Liang X; Jin X; Xie J; Zhang L; Chen D; Fiskesund R; Tang K; Ma J; Zhang H; Dong W; Mo S; Zhang T; Cheng F; Zhou Y; Jia Q; Zhu B; Kong Y; Guo J; Zhang H; Hu ZW; Cao X; Qin FX; Huang B
J Clin Invest; 2018 Mar; 128(3):1057-1073. PubMed ID: 29431732
[TBL] [Abstract][Full Text] [Related]
74. CD10
Su S; Chen J; Yao H; Liu J; Yu S; Lao L; Wang M; Luo M; Xing Y; Chen F; Huang D; Zhao J; Yang L; Liao D; Su F; Li M; Liu Q; Song E
Cell; 2018 Feb; 172(4):841-856.e16. PubMed ID: 29395328
[TBL] [Abstract][Full Text] [Related]
75. Identification of the tumour transition states occurring during EMT.
Pastushenko I; Brisebarre A; Sifrim A; Fioramonti M; Revenco T; Boumahdi S; Van Keymeulen A; Brown D; Moers V; Lemaire S; De Clercq S; Minguijón E; Balsat C; Sokolow Y; Dubois C; De Cock F; Scozzaro S; Sopena F; Lanas A; D'Haene N; Salmon I; Marine JC; Voet T; Sotiropoulou PA; Blanpain C
Nature; 2018 Apr; 556(7702):463-468. PubMed ID: 29670281
[TBL] [Abstract][Full Text] [Related]
76. Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer.
Severson TM; Kim Y; Joosten SEP; Schuurman K; van der Groep P; Moelans CB; Ter Hoeve ND; Manson QF; Martens JW; van Deurzen CHM; Barbe E; Hedenfalk I; Bult P; Smit VTHBM; Linn SC; van Diest PJ; Wessels L; Zwart W
Nat Commun; 2018 Feb; 9(1):482. PubMed ID: 29396493
[TBL] [Abstract][Full Text] [Related]
77. Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer.
Costa A; Kieffer Y; Scholer-Dahirel A; Pelon F; Bourachot B; Cardon M; Sirven P; Magagna I; Fuhrmann L; Bernard C; Bonneau C; Kondratova M; Kuperstein I; Zinovyev A; Givel AM; Parrini MC; Soumelis V; Vincent-Salomon A; Mechta-Grigoriou F
Cancer Cell; 2018 Mar; 33(3):463-479.e10. PubMed ID: 29455927
[TBL] [Abstract][Full Text] [Related]
78. Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Sestak I; Buus R; Cuzick J; Dubsky P; Kronenwett R; Denkert C; Ferree S; Sgroi D; Schnabel C; Baehner FL; Mallon E; Dowsett M
JAMA Oncol; 2018 Apr; 4(4):545-553. PubMed ID: 29450494
[TBL] [Abstract][Full Text] [Related]
79. A Subset of Cancer-Associated Fibroblasts Determines Therapy Resistance.
Huelsken J; Hanahan D
Cell; 2018 Feb; 172(4):643-644. PubMed ID: 29425485
[TBL] [Abstract][Full Text] [Related]
80. Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII-p38MAPK-pS249/T252RB Pathway.
Yu-Lee LY; Yu G; Lee YC; Lin SC; Pan J; Pan T; Yu KJ; Liu B; Creighton CJ; Rodriguez-Canales J; Villalobos PA; Wistuba II; de Nadal E; Posas F; Gallick GE; Lin SH
Cancer Res; 2018 Jun; 78(11):2911-2924. PubMed ID: 29514796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
